IL10 and breast carcinoma: A recent study by Deiployi and colleagues demonstrated that TARE in breast cancer liver metastases demonstrated a heterogeneous pattern of changes to immune markers before and after TARE in 20 patients, including elevation in Il-10 and increased CD4+ tumor infiltration (15 vs. 31%, p < 0.001), with eight patients achieving complete response [139].